Header cover image
  • Investing Ideas
  • /
  • Swiss Pharmaceuticals & Biotech High Return On Equity, Low Debt

Swiss Pharmaceuticals & Biotech High Return On Equity, Low Debt

Results

1

0 new

Stocks with a return on equity of over 30% and a debt to equity ratio below 1.

1 companies

Novartis

Market Cap: CHF 195.7b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

NOVN

CHF 102.00

7D

2.5%

1Y

9.6%